These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15250263)

  • 1. [Hypertensive patients with renal lesion].
    Takagi N
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():31-5. PubMed ID: 15250263
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis.
    Imakiire T; Kikuchi Y; Yamada M; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S
    Hypertens Res; 2007 Jul; 30(7):635-42. PubMed ID: 17785932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension in patients with cardiac hypertrophy].
    Kohno M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():471-7. PubMed ID: 15171418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypertensive nephrosclerosis].
    Fukuda M; Usami T; Kimura G
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():357-62. PubMed ID: 15171399
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ONTARGET still OFF-TARGET?
    Lambers Heerspink HJ; de Zeeuw D
    Circulation; 2011 Mar; 123(10):1049-51. PubMed ID: 21357820
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with angiotensin II antagonists in hypertensive patients.
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S142-6. PubMed ID: 21143288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin II receptor antagonists: a review of the development and future perspective].
    Saito I; Saruta T
    Nihon Rinsho; 1999 May; 57(5):1015-9. PubMed ID: 10361427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive drugs for therapy of hypertension due to long-term hemodialysis].
    Kikawada R; Tsuyusaki T
    Nihon Rinsho; 1991 Dec; 49 Suppl():702-8. PubMed ID: 1687286
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACE inhibitor therapy of hemodialyzed patients].
    Pató E; Radó J
    Orv Hetil; 1997 Jul; 138(30):1903-7. PubMed ID: 9289689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodialysis-associated hypertension; pathophysiology and therapy].
    Suzuki H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():220-4. PubMed ID: 15250299
    [No Abstract]   [Full Text] [Related]  

  • 15. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension].
    Krezsinski JM; Sternon J
    Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertensive treatment in light of the latest discoveries in the renin-angiotensin system].
    Traub Y
    Harefuah; 1996 Feb; 130(3):195-9. PubMed ID: 8682399
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.